Supported exchanges /
NASDAQ /
LIPO.NASDAQ

Lipella Pharmaceuticals Inc. Common Stock (LIPO NASDAQ) stock market data APIs

$0.4 -0.11(-21.5%) as of September 6, 2024

Price chart is built with Anychart

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Lipella Pharmaceuticals Inc. Common Stock Financial Data Overview

Prev. Close	0.5126
Open	0.4
Volume	-
High	0.54
Low	0.3607
52 wk Range	0.3234-2.71
Market Cap	4 154 K
P/E Ratio
Shares Outstanding	8 105 K
Revenue	507 K
EPS	-0.1233
Dividends (Yield)
Beta

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: 'LIPO',

Type: 'Common Stock',

Name: 'Lipella Pharmaceuticals Inc. Common Stock',

Exchange: 'NASDAQ',

CurrencyCode: 'USD',

CurrencyName: 'US Dollar',

CurrencySymbol: '$',

CountryName: 'USA',

CountryISO: 'US',

OpenFigi: 'BBG002GP9137',

ISIN: NULL,

CUSIP: NULL,

CIK: '1347242',

EmployerIdNumber: NULL,

FiscalYearEnd: 'December',

IPODate: '2022-12-19',

InternationalDomestic: NULL,

Sector: 'Healthcare',

Industry: 'Biotechnology',

HomeCategory: NULL,

IsDelisted: false,

}

Lipella Pharmaceuticals Inc. Common Stock Fundamental Data is available in our Financial Data APIs

Net Revenue 507 K
EBITDA -4 744 268
Earnings Per Share -0.61
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $59.99 See full price

Get sample
of Fundamental API Data

Get Lipella Pharmaceuticals Inc. Common Stock Earnings via APIs

Latest Release 2024-08-28
EPS/Forecast NaN

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get Lipella Pharmaceuticals Inc. Common Stock End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$99.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs